Pharmacokinetics of cefixime in patients with impaired renal function
Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacok...
Saved in:
Published in: | Japanese journal of antibiotics Vol. 39; no. 10; p. 2716 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | Japanese |
Published: |
Japan
01-10-1986
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacokinetics of the drug. The results obtained are summarized as follows. The mean peak serum concentration of CFIX in 3 patients with moderately impaired renal function (group I: Ccr greater than or equal to 30-less than 60 ml/min) was 2.04 micrograms/ml at 6 hours after dosing and gradually declined to 0.10 microgram/ml at 24 hours after dosing. The half-life was 4.15 hours. The mean peak serum concentration of CFIX achieved was 2.27 micrograms/ml at 8 hours after dosing in 4 patients with severely impaired renal function (group II: Ccr greater than or equal to 10-less than 30 ml/min) and the concentration of CFIX was 0.99 microgram/ml even after 24 hours. The half-life was prolonged to 11.05 hours. There was no great difference between groups I and II in the first 24-hour urinary excretion rates. However, the first 4-hour urinary excretion accounted for 2.14% of the administered dose of CFIX in group I but only 0.47% in group II. Urinary concentrations of CFIX peaked at 4-6 hours after dosing in both groups, and thereafter gradually decreased in group I. Whereas, they did not decline much in group II until 24 hours after dosing.(ABSTRACT TRUNCATED AT 250 WORDS) |
---|---|
AbstractList | Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacokinetics of the drug. The results obtained are summarized as follows. The mean peak serum concentration of CFIX in 3 patients with moderately impaired renal function (group I: Ccr greater than or equal to 30-less than 60 ml/min) was 2.04 micrograms/ml at 6 hours after dosing and gradually declined to 0.10 microgram/ml at 24 hours after dosing. The half-life was 4.15 hours. The mean peak serum concentration of CFIX achieved was 2.27 micrograms/ml at 8 hours after dosing in 4 patients with severely impaired renal function (group II: Ccr greater than or equal to 10-less than 30 ml/min) and the concentration of CFIX was 0.99 microgram/ml even after 24 hours. The half-life was prolonged to 11.05 hours. There was no great difference between groups I and II in the first 24-hour urinary excretion rates. However, the first 4-hour urinary excretion accounted for 2.14% of the administered dose of CFIX in group I but only 0.47% in group II. Urinary concentrations of CFIX peaked at 4-6 hours after dosing in both groups, and thereafter gradually decreased in group I. Whereas, they did not decline much in group II until 24 hours after dosing.(ABSTRACT TRUNCATED AT 250 WORDS) |
Author | Ishigami, J Arakawa, S Sako, M Fujii, A Maeda, H Kawabata, G Kamidono, S Yamazaki, H Umezu, K Harada, M |
Author_xml | – sequence: 1 givenname: H surname: Maeda fullname: Maeda, H – sequence: 2 givenname: M surname: Sako fullname: Sako, M – sequence: 3 givenname: A surname: Fujii fullname: Fujii, A – sequence: 4 givenname: H surname: Yamazaki fullname: Yamazaki, H – sequence: 5 givenname: G surname: Kawabata fullname: Kawabata, G – sequence: 6 givenname: M surname: Harada fullname: Harada, M – sequence: 7 givenname: S surname: Arakawa fullname: Arakawa, S – sequence: 8 givenname: K surname: Umezu fullname: Umezu, K – sequence: 9 givenname: S surname: Kamidono fullname: Kamidono, S – sequence: 10 givenname: J surname: Ishigami fullname: Ishigami, J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/3806957$$D View this record in MEDLINE/PubMed |
BookMark | eNotj8tKAzEUQLOo1Fr7CUL8gKnJTWeSLKVUKxR0oeuSxw292skMMynq36vY1YGzOHCu2CR3GRm7lWIpZV2rO5cLeeoKhVHaxvilskvQspmwmVCNqUAbeckW40heCDAgra2nbKqMaGytZ2zzcnBD60L3QRn_KrxLPGCiL2qRU-a9K4S5jPyTyoFT2zsaMPIBszvydMqhUJev2UVyxxEXZ87Z28Pmdb2tds-PT-v7XfUuAXTVWC8BY6oFRuHRCIUQNATnlbcrXScA4X611yFaFbBREoV0OqSVMNF6mLOb_25_8i3GfT9Q64bv_XkHfgBHPFJ4 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.11553/antibiotics1968b.39.2716 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 3806957 |
Genre | English Abstract Journal Article |
GroupedDBID | .55 .LE 3O- 53G 5GY 7.U 8GM ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF ECM EIF F5P JSF JSH KQ8 NPM OK1 RJT RZJ SJN TKC X7J X7M ZJWQK ZXP |
ID | FETCH-LOGICAL-j1227-69b12edf50ed0be803e2c72cab3b9475f220ae80b7cd93ce631e01a7cf408d9b2 |
ISSN | 0368-2781 |
IngestDate | Thu May 23 22:58:15 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j1227-69b12edf50ed0be803e2c72cab3b9475f220ae80b7cd93ce631e01a7cf408d9b2 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/antibiotics1968b/39/10/39_2716/_article/-char/en |
PMID | 3806957 |
ParticipantIDs | pubmed_primary_3806957 |
PublicationCentury | 1900 |
PublicationDate | 1986-Oct |
PublicationDateYYYYMMDD | 1986-10-01 |
PublicationDate_xml | – month: 10 year: 1986 text: 1986-Oct |
PublicationDecade | 1980 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Japanese journal of antibiotics |
PublicationTitleAlternate | Jpn J Antibiot |
PublicationYear | 1986 |
SSID | ssib002821995 ssj0000884033 |
Score | 1.3345686 |
Snippet | Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 2716 |
SubjectTerms | Administration, Oral Adult Aged Cefixime Cefotaxime - administration & dosage Cefotaxime - analogs & derivatives Cefotaxime - metabolism Drug Administration Schedule Female Half-Life Humans Kidney Diseases - drug therapy Kidney Diseases - metabolism Kinetics Male Middle Aged |
Title | Pharmacokinetics of cefixime in patients with impaired renal function |
URI | https://www.ncbi.nlm.nih.gov/pubmed/3806957 |
Volume | 39 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bS-QwFA4zKy6-iJeV9UoE8cnupmnatI-LjviiCI6gT5JboSMzI6uC-us9aZJpZ0TRB19KSWinzfdNcnJ6zncQ2uPKJlzmMkrjMo8Y1UUkNGxWmE64YEIQZuwX3ZMLfnaVH_VYr9MJcVxN27ciDW2Atc2c_QLak5tCA5wD5nAE1OH4KdzPvRb1LZiPtQSzjRs3ZfVUDWt9EC-k6rPabJJkZUPQ_xtrltpVboJUMFlhObVlKtsiEwBHJavxQytU_lQYLaayHS7E7XjK33r8OKiqKf_ptRiKF9GqnO0cEHGRZ5NQtibxCiDgrvJKmFSdQlEgD2lPkdwlV76du9O6AkfrDWB2yOUfm080cw0M-d2wBjDJSVY4iesPO2dEtX1PF3XBQrJG9GHj44FNqM1bn3jqYB5mJHF1tv2b_kS74Yn_vve8C2je_8rMjqW2XPpLaNFvOfA_x5Vl1BmIFbTvefJ8gPtNCt79Ad7H542a-fMq6s0SCo9LHAiFqxEOhMKWUDgQCteEwoFQv9Dlca9_eBL52hvRIKaUR1khY2p0mRKjiTQ5SQxVnCohE1kwnpaUEgHNkitdJMpkSWxILLgqGcl1Ieka-jEaj8xvhLnimZKCS5kyWC7AQDRgF1Km4E4pLMbraM0Nz82dE1i58eO28V7HJlpoiLiF5kr475pt1L3Xjzs1lq9YL2KW |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics+of+cefixime+in+patients+with+impaired+renal+function&rft.jtitle=Japanese+journal+of+antibiotics&rft.au=Maeda%2C+H&rft.au=Sako%2C+M&rft.au=Fujii%2C+A&rft.au=Yamazaki%2C+H&rft.date=1986-10-01&rft.issn=0368-2781&rft.volume=39&rft.issue=10&rft.spage=2716&rft_id=info:doi/10.11553%2Fantibiotics1968b.39.2716&rft_id=info%3Apmid%2F3806957&rft_id=info%3Apmid%2F3806957&rft.externalDocID=3806957 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0368-2781&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0368-2781&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0368-2781&client=summon |